Laura Kornblihtt

485 total citations
26 papers, 321 citations indexed

About

Laura Kornblihtt is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Laura Kornblihtt has authored 26 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 14 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Laura Kornblihtt's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Laura Kornblihtt is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Laura Kornblihtt collaborates with scholars based in Argentina, Italy and Mexico. Laura Kornblihtt's co-authors include Felisa C. Molinas, Paula G. Heller, Rosana F. Marta, Ana C. Glembotsky, Carlos J. Pirola, Paola R. Lev, Liliana M.E. Finocchiaro, Nora P. Goette, Manish J. Gandhi and Jonathan G. Drachman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Stroke.

In The Last Decade

Laura Kornblihtt

26 papers receiving 310 citations

Peers

Laura Kornblihtt

GENET

HEMAT

RHEUM

PRM

M. Nagel‐Hiemke Germany

J. Brett Heimlich United States

Laura Fazzuoli Italy

Emiri Miura‐Yura Japan

Adam C. Strauss United States

Hayden Ollivierre United States

Grace Collord United Kingdom

Osamu Shinohara Japan

Sharon M Cawley United States

John Taper Australia

M. Nagel‐Hiemke Germany

Laura Kornblihtt

102 ×0.6

GENET

144 ×0.9

HEMAT

52 ×0.4

156 ×2.0

RHEUM

37 ×1.2

PRM

Citations per year, relative to Laura Kornblihtt Laura Kornblihtt (= 1×) peers M. Nagel‐Hiemke

Countries citing papers authored by Laura Kornblihtt

Since Specialization

Citations

This map shows the geographic impact of Laura Kornblihtt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Kornblihtt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Kornblihtt more than expected).

Fields of papers citing papers by Laura Kornblihtt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Kornblihtt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Kornblihtt. The network helps show where Laura Kornblihtt may publish in the future.

Co-authorship network of co-authors of Laura Kornblihtt

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Kornblihtt. A scholar is included among the top collaborators of Laura Kornblihtt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Kornblihtt. Laura Kornblihtt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Enrico, Alicia, Andrés Gómez‐De León, Elvira Deolinda Rodrigues Pereira Velloso, et al.. (2024). Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up. Blood. 144(Supplement 1). 6718–6718. 1 indexed citations

Kornblihtt, Laura, et al.. (2022). Metabolic plasticity in blast crisis-chronic myeloid leukaemia cells under hypoxia reduces the cytotoxic potency of drugs targeting mitochondria. Discover Oncology. 13(1). 60–60. 5 indexed citations

Grille, Sofía, et al.. (2022). Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam. Blood. 140(Supplement 1). 4096–4097. 2 indexed citations

Kornblihtt, Laura, et al.. (2020). A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and metabolic reprogramming under hypoxia. Toxicology and Applied Pharmacology. 398. 115016–115016. 1 indexed citations

Kornblihtt, Laura, et al.. (2019). [Preferences and limitations of hematologists to address the complexity of myelodysplastic syndromes].. PubMed. 79(3). 174–184. 1 indexed citations

Kornblihtt, Laura, et al.. (2014). Sipunculan celomocytes increase the resistance to H2O2-induced cell death under hypoxia. SHILAP Revista de lepidopterología. 11(1). 87–102. 1 indexed citations

Costantino, Susana N., et al.. (2014). Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine. European Journal of Cancer. 50(18). 3243–3261. 12 indexed citations

Kornblihtt, Laura, et al.. (2013). Prognostic Implications of Cytogenetic Features in Myelodysplastic Syndromes. 9(1). 60–60. 1 indexed citations

Costantino, Susana N., et al.. (2011). Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion. Toxicology and Applied Pharmacology. 258(3). 351–366. 9 indexed citations

10.

Goette, Nora P., Paola R. Lev, Paula G. Heller, et al.. (2010). Monocyte IL-2Rα expression is associated with thrombosis and the JAK2V617F mutation in myeloproliferative neoplasms. Cytokine. 51(1). 67–72. 14 indexed citations

11.

Heller, Paula G., Paola R. Lev, Laura Kornblihtt, et al.. (2006). JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status. European Journal Of Haematology. 77(3). 210–216. 50 indexed citations

12.

Heller, Paula G., Ana C. Glembotsky, Manish J. Gandhi, et al.. (2005). Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood. 105(12). 4664–4670. 65 indexed citations

13.

Lev, Paola R., Laura Kornblihtt, Carlos J. Pirola, et al.. (2005). PDGF-A, PDGF-B, TGF?, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide. American Journal of Hematology. 78(2). 155–157. 10 indexed citations

14.

Kornblihtt, Laura, et al.. (2005). Moyamoya Syndrome in an Adolescent With Essential Thrombocythemia. Stroke. 36(8). E71–3. 27 indexed citations

15.

Marta, Rosana F., Nora P. Goette, Paola R. Lev, et al.. (2004). Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.. PubMed. 89(6). 657–63. 7 indexed citations

16.

Kornblihtt, Laura, et al.. (2003). Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations. Thrombosis Research. 112(3). 131–135. 9 indexed citations

17.

Kornblihtt, Laura, et al.. (2000). Tromboxano B2 y factor de crecimiento derivado de las plaquetas en la trombocitemia esencial tratada con anagrelide. Medicina-buenos Aires. 1 indexed citations

18.

Kornblihtt, Laura, Liliana M.E. Finocchiaro, & Felisa C. Molinas. (1993). Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid. Journal of Pineal Research. 14(4). 184–191. 28 indexed citations

19.

Myśliwiec, M, Silvia Villa, Laura Kornblihtt, Giovanni de Gaetano, & Maria Benedetta Donati. (1980). Decreased plasminogen activator but normal prostacyclin activity in rat veins during development of experimental thrombosis. Thrombosis Research. 18(1-2). 159–165. 5 indexed citations

20.

Donati, Maria Benedetta, L. Mussoni, Laura Kornblihtt, & Andreina Poggi. (1977). Changes in the hemostatic system of rats bearing L5222 or BNML experimental leukemias. Leukemia Research. 1(2-3). 177–180. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact